Panagene Inc
KOSDAQ:046210
Panagene Inc
Cost of Revenue
Panagene Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
P
|
Panagene Inc
KOSDAQ:046210
|
Cost of Revenue
-₩4B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-8%
|
Celltrion Inc
KRX:068270
|
Cost of Revenue
-₩1.1T
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-32%
|
|
SK Bioscience Co Ltd
KRX:302440
|
Cost of Revenue
-₩227.3B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
|
H
|
Hugel Inc
KOSDAQ:145020
|
Cost of Revenue
-₩73.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
P
|
PharmaResearch Co Ltd
KOSDAQ:214450
|
Cost of Revenue
-₩70.8B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
A
|
Alteogen Inc
KOSDAQ:196170
|
Cost of Revenue
-₩65.3B
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
See Also
What is Panagene Inc's Cost of Revenue?
Cost of Revenue
-4B
KRW
Based on the financial report for Dec 31, 2023, Panagene Inc's Cost of Revenue amounts to -4B KRW.
What is Panagene Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-8%
Over the last year, the Cost of Revenue growth was 11%. The average annual Cost of Revenue growth rates for Panagene Inc have been 9% over the past three years , -4% over the past five years , and -8% over the past ten years .